As a testosterone replacement therapy, AndriolTestoapps capsules can effectively improve symptoms of male hypogonadism, but medication should be standardized and gradually discontinued to avoid hormonal fluctuations. During the treatment period, it is necessary to regularly monitor the efficacy indicators. When stopping medication, the principle of stepwise reduction should be followed and relevant risks should be noted.

1. Therapeutic effect

(1) Sexual function improvement: can significantly enhance libido, erectile function, and sperm production ability, usually showing results after 3-6 months of treatment.

(2) Metabolic regulation: can improve muscle mass loss, osteoporosis, and abnormal fat distribution, requiring exercise and nutritional intervention.

(3) Psychological state: It has a relieving effect on symptoms such as low mood and cognitive decline, but primary mental illness needs to be ruled out.

2. Precautions for discontinuation of medication

(1) Reduction principle: Long term medication users should reduce their dosage by 25% every 2-4 weeks, with a total treatment period of no less than 4 weeks, to avoid sudden arrest leading to rebound low testosterone.

(2) Monitoring indicators: Regularly measure serum testosterone, LH, and FSH levels within 3 months after discontinuation of medication to evaluate the recovery of the hypothalamic pituitary gonadal axis.

(3) Symptom observation: Pay attention to withdrawal symptoms such as fatigue, depression, and decreased sexual function, and restart low-dose treatment transition if necessary.

3. Special Risk Warning

(1) Prostate monitoring: PSA should still be checked every 6 months after discontinuation of medication, as withdrawal of androgens may accelerate the progression of occult prostate disease.

(2) Osteoporosis: For those who stop taking medication after long-term treatment, it is recommended to supplement calcium and vitamin D, and undergo bone density tracking testing.

(3) Metabolic rebound: It is necessary to prevent the risk of worsening metabolic syndrome such as increased body fat percentage and decreased insulin sensitivity after discontinuation of medication.